Carmignac Gestion’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-46,369
Closed -$1.52M 125
2021
Q4
$1.52M Sell
46,369
-127,471
-73% -$4.34M 0.02% 107
2021
Q3
$7.29M Sell
173,840
-12,699
-7% -$457K 0.09% 79
2021
Q2
$7.25M Sell
186,539
-66,463
-26% -$2.38M 0.08% 80
2021
Q1
$8.63M Buy
253,002
+166,600
+193% +$7.11M 0.1% 75
2020
Q4
$3.92M Sell
86,402
-59,626
-41% -$2.08M 0.04% 90
2020
Q3
$4.02M Sell
146,028
-27,164
-16% -$886K 0.05% 74
2020
Q2
$6.38M Buy
173,192
+4,287
+3% +$160K 0.09% 68
2020
Q1
$5.47M Sell
168,905
-120,376
-42% -$5.02M 0.09% 61
2019
Q4
$11.9M Sell
289,281
-954,440
-77% -$37.7M 0.16% 50
2019
Q3
$44.3M Sell
1,243,721
-138,541
-10% -$5.61M 0.56% 44
2019
Q2
$71M Buy
1,382,262
+743,067
+116% +$37.1M 0.88% 39
2019
Q1
$36.6M Buy
639,195
+467,869
+273% +$23.2M 0.43% 43
2018
Q4
$7.19M Buy
171,326
+60,020
+54% +$3.52M 0.11% 66
2018
Q3
$8.4M Buy
111,306
+33,305
+43% +$2.4M 0.07% 78
2018
Q2
$5.6M Buy
+78,001
New +$3.72M 0.04% 85

Other funds holding RGNX